Literature DB >> 8051153

A nonexchangeable apolipoprotein E peptide that mediates binding to the low density lipoprotein receptor.

M P Mims1, A T Darnule, R W Tovar, H J Pownall, D A Sparrow, J T Sparrow, D P Via, L C Smith.   

Abstract

ApoE is a 34-kDa apoprotein that mediates lipoprotein binding to the low density lipoprotein (LDL) receptor and to the LDL receptor-related protein. Receptor binding is mediated by a highly basic, alpha-helical sequence of approximately 15 amino acids that interacts with cysteine-rich repeat regions of the receptor. To determine the relationship between the receptor binding and lipid associating properties of apoE, we have synthesized a series of apoE peptides containing all (residues 129-169) or part (residues 139-169, 144-169, and 148-169) of the receptor-binding domain. The lipophilicity of these peptides was increased by modification of their N termini by acylation with either palmitic acid (C16-apoE peptide) or the N,N-distearyl derivative of glycine (diC18-Gly-apoE peptide). The unmodified peptides demonstrated low affinity for lipid surfaces (Kd > 10(-5) M) and moderate alpha-helicity in the presence of lipid (40%) and had no effect on LDL uptake by fibroblasts. N-Palmitoyl peptides had increased affinity for lipid (Kd approximately 10(-6) M) and increased alpha-helicity (55%) in the presence of lipid. The addition of the C16-apoE-(129-169)-peptide to 125I-LDL enhanced its uptake and degradation by fibroblasts 8-10-fold; however, < 50% of the degradation was mediated by the LDL receptor. By contrast, the diC18-Gly-apoE-(129-169)-peptide was essentially nonexchangeable (Kd < or = 10(-9) M) and highly helical (78%) in the presence of lipid. The addition of the diC18-Gly-apoE-(129-169)-peptide to 125I-LDL enhanced the specific uptake and degradation of LDL by both LDL receptor-mediated and non-LDL receptor-mediated mechanisms. Uptake and degradation of methylated LDL containing diC18-Gly-apoE-(129-169) revealed that the lipoprotein-bound peptide is the active agent. In agreement with this finding, a mutant diC18-Gly-apoE peptide (Arg142-->Gln) was much less effective than the wild-type peptide in potentiating binding, uptake, and degradation of 125I-LDL. Complexes of diC18-Gly-apoE-(129-169), apoA-I, and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine containing four to six copies of the peptide/particle displayed an affinity for the LDL receptor similar to that of apoE-L-alpha-dimyristoylphosphatidylcholine discs containing four copies of apoE.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051153

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  NMR studies of the low-density lipoprotein receptor-binding peptide of apolipoprotein E bound to dodecylphosphocholine micelles.

Authors:  D Clayton; I M Brereton; P A Kroon; R Smith
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  Structure of the minimal interface between ApoE and LRP.

Authors:  Miklos Guttman; J Helena Prieto; Tracy M Handel; Peter J Domaille; Elizabeth A Komives
Journal:  J Mol Biol       Date:  2010-03-19       Impact factor: 5.469

3.  An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo.

Authors:  I R Nikoulin; L K Curtiss
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

4.  Mechanisms of peptide amphiphile internalization by SJSA-1 cells in vitro.

Authors:  Dimitris Missirlis; Htet Khant; Matthew Tirrell
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

5.  Decoding of lipoprotein-receptor interactions: properties of ligand binding modules governing interactions with apolipoprotein E.

Authors:  Miklos Guttman; J Helena Prieto; Johnny E Croy; Elizabeth A Komives
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

Review 6.  High-density lipoproteins, reverse cholesterol transport and atherogenesis.

Authors:  Henry J Pownall; Corina Rosales; Baiba K Gillard; Antonio M Gotto
Journal:  Nat Rev Cardiol       Date:  2021-04-08       Impact factor: 32.419

Review 7.  Nanoparticles for brain drug delivery.

Authors:  Massimo Masserini
Journal:  ISRN Biochem       Date:  2013-05-21

8.  Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for the treatment of Alzheimer's disease.

Authors:  Anna Binda; Alice Panariti; Andrea Barbuti; Carmen Murano; Roberta Dal Magro; Massimo Masserini; Francesca Re; Ilaria Rivolta
Journal:  Int J Nanomedicine       Date:  2018-07-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.